Metraipolis › archive › dc_162caea8d7f4

Drug sequestration and metabolite formation: key pharmacokinetic challenges for levosimendan use during ECMO support in cardiogenic shock — Europe PMC PMID:42032778

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42032778
DOI
10.1186/s40560-[numero omesso]-5
License (as archived)
solo-consultazione
Archived
2026-11-03T07:03:51.499Z
SHA-256 of the archived text
4631e7037c69ceeac767e7436c18734ad2cf985c9c67209b74417cec1b6356ed
Stable URL of this page
https://metraipolis.com/documento/dc_162caea8d7f4

How to cite

Drug sequestration and metabolite formation: key pharmacokinetic challenges for levosimendan use during ECMO support in cardiogenic shock — Europe PMC PMID:42032778 — Europe PMC (en), https://europepmc.org/article/MED/42032778 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_162caea8d7f4 (Metraipolis archive dc_162caea8d7f4, sha256 4631e7037c69ceeac767e7436c18734ad2cf985c9c67209b74417cec1b6356ed)
BibTeX
@misc{dc162caea8d7f4,
  title = {Drug sequestration and metabolite formation: key pharmacokinetic challenges for levosimendan use during ECMO support in cardiogenic shock — Europe PMC PMID:42032778},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42032778},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_162caea8d7f4; sha256 4631e7037c69ceeac767e7436c18734ad2cf985c9c67209b74417cec1b6356ed},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42032778. Agents can read the archived copy with the MCP tool read_document.